Chang Moo Kang

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials”.

Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials

Cancer Communications(2022)10.1002/cac2.12251

N/A

0DataRank · unranked

7 citations

Yun Seong Jeong, Sunyoung Lee, Bo Hwa Sohn, Ho Kyoung Hwang, Gi Hong Choi +11 more

Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen

Frontiers in Immunology(2024)10.3389/fimmu.2024.1429335

N/A

0DataRank · unranked

10 citations

Ju Hua Wang, Dongin Kim, Chang Moo Kang, Katja Brion, Sean Bickerton +2 more

CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-β-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disorders

Frontiers in Immunology(2025)10.3389/fimmu.2025.1587237

N/A

0DataRank · unranked

3 citations

Dongin Kim, Chang Moo Kang, Katja Brion, Sean Bickerton, Antonio La Cava +1 more